Dr. Reddy's Laboratories Ltd. closed 19.44% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, has been elected to ...

Natixis Advisors LLC increased its position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 422.7% in the 4th quarter, according to the company in its most recent filing with ...

HYDERABAD: Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. Food and Drug Administration, FDA, has accepted a 351(k) Biologic ...

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into ...

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into ...

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has signed agreements today to acquire a basket of 14 Abbreviated New Drug ...

Senores Pharmaceuticals rallied 5.69% to 560.60 after its subsidiary, Senores Pharmaceuticals, Inc. (SPI), USA, has signed agreements to acquire 14 Abbreviated New Drug Applications (ANDAs) from Dr.

The stock advanced after the company through its subsidiary Senores Pharmaceuticals, Inc., USA, acquired 14 Abbreviated New Drug Applications (ANDAs) from Dr. Reddy’s Laboratories. Around 2:27 PM, ...